The neutrophil to lymphocyte ratio, platelet to lymphocyte ratio, and mean platelet volume in patients with chronic otitis media and cholesteatoma
The neutrophil to lymphocyte ratio, platelet to lymphocyte ratio, and mean platelet volume in patients with chronic otitis media and cholesteatoma
Aim: The neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and mean platelet volume (MPV) are widely usedsimple markers of subclinical inflammation. We explored whether these parameters were affected in patients with chronic otitismedia (COM) with and without cholesteatoma.Material and Methods: We studied 295 COM patients operated upon in our hospital and 135 healthy subjects were devoid ofinflammation (controls). The patients were divided into two groups depending on cholesteatoma status: COM with cholesteatoma(the COMch group) and COM without cholesteatoma (the COM group). The groups were compared in terms of their NLRs, PLRs, andMPVs. The NLR and PLR were calculated by dividing the numbers of neutrophils and platelets by that of lymphocytes.Results: Of the 295 patients, 149 and 146 had COMch and COM, respectively. No significant difference (P 0.05) was evident in anyof NLR, PLR, or MPV between the study groups.Conclusion: None of LNR, PLR, or MPV differed significantly in COM patients with and without cholesteatoma. Although inflammationplays an important role in cholesteatoma pathogenesis, any effect thereof is local rather than systemic.
___
- 1. Chirwa M, Mulwafu W, Aswani JM, et al. Microbiology of
chronic suppurative otitis media at Queen Elizabeth Central
Hospital, Blantyre, Malawi: A cross-sectional descriptive
study. Malawi Med J 2015;27:120-4.
- 2. Hamed MA, Nakata S, Sayed RH, et al. Pathogenesis and Bone
Resorption in Acquired Cholesteatoma: Current Knowledge
and Future Prospectives. Clin Exp Otorhinolaryngol.
2016;9:298-308.
- 3. Gaillardin L, Lescanne E, Moriniere S, et al. Residual
cholesteatoma: prevalence and location. Follow-up
strategy in adults. Eur Ann Otorhinolaryngol Head Neck Dis
2012;129:136–40.
- 4. Akkari M, Gabrillargues J, Saroul N, et al. Contribution of
magnetic resonance imaging to the diagnosis of middle ear
cholesteatoma: analysis of a series of 97 cases. Eur Ann
Otorhinolaryngol Head Neck Dis 2014;131:153-8.
- 5. Ho SY, Kveton JF. Efficacy of the 2-staged procedure in the
management of cholesteatoma. Arch Otolaryngol Head
Neck Surg 2003;129:541-5.
- 6. Kum RO, Ozcan M, Baklaci D, Yurtsever KN, Yilmaz YF, Unal
A, et al. Investigation of neutrophil-to-lymphocyte ratio
and mean platelet volume in sudden hearing loss. Braz J
Otorhinolaryngol 2015;81:636-41.
- 7. Ozler GS, Gunak G. Neutrophil–lymphocyte ratio: a new
predictive and prognostic factor in patients with Bell palsy. J
Craniofac Surg 2014;25:944–5.
- 8. Atan D, Apaydin E, Ozcan KM, et al. New diagnostic
indicators in chronic otitis media with effusion: neutrophil
to lymphocyte ratio and thrombocyte lymphocyte ratio. ENT
Updates 2016;6:12-5.
- 9. Vaid S, Kamble Y, Vaid N, et al. Role of magnetic resonance
imaging in cholesteatoma: the Indian experience. Indian J
Otolaryngol Head Neck Surg 2013;65:485-92.
- 10. Pauna HF, Monsanto RC, Schachern P, et al. Evidence
against the mucosal traction theory in cholesteatoma.
Laryngoscope. 2018;128:1663-7.
- 11. Yamashita K, Yoshiura T, Hiwatashi A, et al. Contributing
factors in the pathogenesis of acquired cholesteatoma:
size analysis based on MDCT. AJR Am J Roentgenol
2011;196:1172-5.
- 12. Schilling V, Bujia J, Negri B, et al. Immunologically activated
cells in aural cholesteatoma. Am J Otolaryngol 1991;12:249-
53.
- 13. Lampikoski H, Aarnisalo AA, Jero J, et al. Mastoid biofilm in
chronic otitis media. Otol Neurotol 2012;33:785-8.
- 14. Yellon RF, Leonard G, Marucha PT, et al. Characterization
of cytokines present in middle ear effusions. Laryngoscope
1991;101:165-9.
- 15. Louw L. Acquired cholesteatoma: summary of the cascade
of molecular events. J Laryngol Otol 2013;127:542-9.
- 16. Tamhane UU, Aneja S, Montgomery D, et al. Association
between admission neutrophil to lymphocyte ratio and
outcomes in patients with acute coronary syndrome. Am J
Cardiol 2008;102:653-7.
- 17. Gasparyan AY, Ayvazyan L, Mikhailidis DP, et al. Mean platelet
volume: a link between thrombosis and inflammation? Curr
Pharm Des 2011;17:47-58.
- 18. Seo YJ, Jeong JH, Choi JY, et al. Neutrophil-to-lymphocyte
ratio and platelet-to-lymphocyte ratio: novel markers for
diagnosis and prognosis in patients with idiopathic sudden
sensorineural hearing loss. Dis Markers 2014;2014:702807.
- 19. Kemal Y, Yucel I, Ekiz K, et al. Elevated serum neutrophil
to lymphocyte and platelet to lymphocyte ratios could be
useful in lung cancer diagnosis. Asian Pac J Cancer Prev
2014;15:2651-4.
- 20. Ozbay I, Kahraman C, Balikci HH, et al. Neutrophil-tolymphocyte
ratio in patients with peripheral vertigo: a
prospective controlled clinical study. Am J Otolaryngol
2014;35:699-702.